Florida Health Daily
SEE OTHER BRANDS

Your best source on healthcare and wellness news from Florida

Florida Health Daily: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Florida Health Daily.

Press releases published on April 24, 2025

Seer to Report First Quarter 2025 Financial Results on May 13, 2025

Seer to Report First Quarter 2025 Financial Results on May 13, 2025

REDWOOD CITY, Calif., April 24, 2025 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), a leading life sciences company commercializing a disruptive new platform for proteomics, today announced that it will report financial results for the first quarter 2025 …

Merit Medical Reports First Quarter 2025 Results and Updates Full-Year Guidance

Merit Medical Reports First Quarter 2025 Results and Updates Full-Year Guidance

First Quarter Highlights† Reported revenue of $355.4 million, up 9.8% Constant currency revenue* and constant currency revenue, organic* up 10.9% and up 6.0%, respectively GAAP operating margin of 11.5%, compared to 11.1% in prior year period Non-GAAP …

Catheter Precision to Attend and Participate in the 46th Heart Rhythm Society

Catheter Precision to Attend and Participate in the 46th Heart Rhythm Society

Fort Mill, S.C., April 24, 2025 (GLOBE NEWSWIRE) -- Catheter Precision, Inc. (VTAK - NYSE/American), a US based medical device company focused on developing technologically advanced products for the cardiac electrophysiology market announced their …

PROCEPT BioRobotics' Aquablation Therapy Spotlighted at 2025 AUA Annual Meeting Along with Expert-Led Workshops

PROCEPT BioRobotics' Aquablation Therapy Spotlighted at 2025 AUA Annual Meeting Along with Expert-Led Workshops

Presentations underscore long-term clinical outcomes, safety and durability in BPH treatment Attendees invited to experience hands-on HYDROS Robotic System demonstrations SAN JOSE, Calif., April 24, 2025 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation …

Inventiva announces the publication in Clinical Gastroenterology and Hepatology of its analysis of new biomarker signatures predictive of histological response in patients with MASH treated with lanifibranor

Inventiva announces the publication in Clinical Gastroenterology and Hepatology of its analysis of new biomarker signatures predictive of histological response in patients with MASH treated with lanifibranor

► Biomarker signatures were developed to predict histological treatment response to lanifibranor treatment in patients with MASH and fibrosis ► The biomarker signatures developed for fibrosis improvement, MASH resolution and composite histological …

Inventiva annonce la publication dans Clinical Gastroenterology and Hepatology de l’analyse de nouvelles signatures de biomarqueurs prédictives de la réponse histologique chez les patients atteints de MASH traités par lanifibranor

Inventiva annonce la publication dans Clinical Gastroenterology and Hepatology de l’analyse de nouvelles signatures de biomarqueurs prédictives de la réponse histologique chez les patients atteints de MASH traités par lanifibranor

► Des signatures de biomarqueurs ont été développées pour prédire la réponse histologique au traitement par lanifibranor chez les patients atteints de MASH avec fibrose ► Les signatures de biomarqueurs développées pour l’amélioration de la fibrose, la …

Ascendis Pharma to Report First Quarter 2025 Financial Results and Provide Business Update on May 1, 2025

Ascendis Pharma to Report First Quarter 2025 Financial Results and Provide Business Update on May 1, 2025

COPENHAGEN, Denmark, April 24, 2025 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND) today announced it will report first quarter 2025 financial results and provide a business update on Thursday, May 1, 2025, after the close of the U.S. financial …

Kiniksa Pharmaceuticals to Report First Quarter 2025 Financial Results on April 29, 2025

Kiniksa Pharmaceuticals to Report First Quarter 2025 Financial Results on April 29, 2025

LONDON, April 24, 2025 (GLOBE NEWSWIRE) -- Kiniksa Pharmaceuticals International, plc (Nasdaq: KNSA) announced today that it will host a conference call and live webcast on Tuesday, April 29, 2025 at 8:30 a.m. Eastern Time to report its first quarter 2025 …

Effective May 2, 2025, Interpace Diagnostics® Will No Longer Accept Specimens for PancraGEN®, a Molecular Diagnostic Test That Assesses Pancreatic Cyst Cancer Risk

Effective May 2, 2025, Interpace Diagnostics® Will No Longer Accept Specimens for PancraGEN®, a Molecular Diagnostic Test That Assesses Pancreatic Cyst Cancer Risk

Interpace Expects to Remain Profitable as a Thyroid-focused Business PARSIPPANY, NJ, April 24, 2025 (GLOBE NEWSWIRE) -- Interpace Diagnostics®, a subsidiary of Interpace Biosciences®, (“Interpace” or the “Company”) (OTCQX: IDXG) today announced that the …

Progyny, Inc. Announces Details for Its First Quarter 2025 Results Report

Progyny, Inc. Announces Details for Its First Quarter 2025 Results Report

NEW YORK, April 24, 2025 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a global leader in women’s health and family building, will report its financial results for the quarterly period ended March 31, 2025, after the close of the market on Thursday, …

May is Brain Cancer Awareness Month: Illuminate the Fight Against One of the Most Lethal Cancers

May is Brain Cancer Awareness Month: Illuminate the Fight Against One of the Most Lethal Cancers

TORONTO, April 24, 2025 (GLOBE NEWSWIRE) -- This May, Brain Cancer Canada (BCC) and communities across the country prepare to rally for Brain Cancer Awareness Month. Dedicated to supporting those impacted by brain cancer, the community goes “Grey In May” …

Tenaya Therapeutics Presents Interim Data from RIDGE™ Natural History and Seroprevalence Study of Adults with PKP2-associated ARVC at Heart Rhythm 2025

Tenaya Therapeutics Presents Interim Data from RIDGE™ Natural History and Seroprevalence Study of Adults with PKP2-associated ARVC at Heart Rhythm 2025

RIDGE is Largest Natural History Study Conducted with More Than 175 Participants Enrolled to Date with Arrhythmogenic Right Ventricular Cardiomyopathy Due to Mutations in the PKP2 Gene Patients Experience High Burden of Arrhythmias and Severe Disease …

Faraday Pharmaceuticals to Host Satellite Symposium at SCAI 2025 on Exploring New Frontiers in Reducing Ischemia-Reperfusion Injury

Faraday Pharmaceuticals to Host Satellite Symposium at SCAI 2025 on Exploring New Frontiers in Reducing Ischemia-Reperfusion Injury

SEATTLE, April 24, 2025 (GLOBE NEWSWIRE) -- Faraday Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company focused on preventing heart failure by reducing myocardial damage in acute ST-elevation myocardial infarction (STEMI) through the …

HealthPRO Canada and the CAN Health Network Join Forces  to Accelerate Procurement of Made-in-Canada Healthcare Innovations

HealthPRO Canada and the CAN Health Network Join Forces to Accelerate Procurement of Made-in-Canada Healthcare Innovations

Oakville, ON, April 24, 2025 (GLOBE NEWSWIRE) -- HealthPRO Canada, the country’s national group contracting provider for healthcare, is proud to announce a strategic partnership with the CAN Health Network (CAN Health) to accelerate the adoption and …

Imprivata Names Joel Burleson-Davis as Chief Technology Officer

Imprivata Names Joel Burleson-Davis as Chief Technology Officer

WALTHAM, Mass., April 24, 2025 (GLOBE NEWSWIRE) -- Imprivata, the digital identity company for life- and mission-critical industries, today announced the appointment of Joel Burleson-Davis to Chief Technology Officer (CTO). Serving most recently as SVP of …

Healing with Data: Transforming Pediatric Care at Leading Maternal and Children’s Hospital Sant Joan de Déu

Healing with Data: Transforming Pediatric Care at Leading Maternal and Children’s Hospital Sant Joan de Déu

Leading Spanish hospital Relies on Denodo Platform for Real-time patient data monitoring and AI-driven analytics, updating data every 30 seconds PALO ALTO, Calif., April 24, 2025 (GLOBE NEWSWIRE) -- Denodo, a leader in data management, announced that …

Dig In! Moley Leads the Charge for Global Action Days

Dig In! Moley Leads the Charge for Global Action Days

London, April 24, 2025 (GLOBE NEWSWIRE) -- Get ready to stomp, soak, drum and dance — because Global Action Days has officially begun, and it’s all happening beneath our feet! Kicking off on Earth Day and continuing for two action-packed weeks, the …

Global Neuroprosthetics Market Expanding Rapidly at a CAGR of ~13% by 2032 Amid Surge in Demand for Advanced Neurological Treatments | DelveInsight

Global Neuroprosthetics Market Expanding Rapidly at a CAGR of ~13% by 2032 Amid Surge in Demand for Advanced Neurological Treatments | DelveInsight

New York, USA, April 24, 2025 (GLOBE NEWSWIRE) -- Global Neuroprosthetics Market Expanding Rapidly at a CAGR of ~13% by 2032 Amid Surge in Demand for Advanced Neurological Treatments | DelveInsight The neuroprosthetics market is experiencing significant …

Sarcopenia Clinical Trial Pipeline Appears Robust With 18+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight

Sarcopenia Clinical Trial Pipeline Appears Robust With 18+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight

New York, USA, April 24, 2025 (GLOBE NEWSWIRE) -- Sarcopenia Clinical Trial Pipeline Appears Robust With 18+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight The sarcopenia market remains largely untapped, with significant …

Huer Foods teams up with BC Women’s Health Foundation to raise funds for infant MRI machine

Huer Foods teams up with BC Women’s Health Foundation to raise funds for infant MRI machine

LANGLEY, British Columbia, April 24, 2025 (GLOBE NEWSWIRE) -- This summer, British Columbians can give back to an important local cause while enjoying a delectable candy treat! Huer Foods—a local candy brand based in BC’s Lower Mainland—has launched a …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service